Jacques Essinger

Operating Partner

Jacques joined Endeavour in 2017 and brings more than 30 years of entrepreneurial experience in medical devices ranging from product design, clinical and regulatory validation, scale-up and commercial growth, financing, IPO and trade-sale.

He is currently acting CEO of Polares and Endostim. He was CEO of Symetis SA, which he grew from concept to an established global market player in the field of Transcatheter Aortic Valve Implant (TAVI). Symetis was acquired by Boston Scientific in March 2017, at the time of acquisition, Symetis was N°3 in Europe.

Prior to Symetis, Jacques was CEO of Isotis, a tissue-processing company which he brought public in 2000, acquired by Integra Lifescience in 2007. He also founded and developed Symbios Orthopedie SA, a world leader in the field of custom hip implants.

Jacques has a MSc in physics and a PhD in biomechanics from the EPFL (Lausanne).

Polares: View Company Profile

Board member
Nuvaira: View Company Profile
V-Wave: View Company Profile
Gynesonics: View Company Profile

Former CEO
Symetis: View Company Profile
IsoTis Orthobiologics
Symbios Orthopedie: View Company Profile

Symbios Orthopedie: View Company Profile

Back to the Team